News | January 03, 2024
WuXi XDC partners with IntoCell to accelerate ADC discovery and development
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
Eris Lifesciences enters into term loan agreement with Citi Bank
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Subscribe To Our Newsletter & Stay Updated
